Literature DB >> 11908171

[Androgenic alopecia revealing an androgen secreting ovarian tumor].

S Roux-Guinot1, I Gorin, D Vadrot, R Djid, J P Bethoux, J P Escande.   

Abstract

INTRODUCTION: Androgen-producing tumors of the ovary are rare in postmenopausal women and are revealed by severe virilization. Leydig hilus cell tumors are the most frequent postmenopausal virilizing tumors. In this report, an unusual and rare cause of alopecia due to Leydig cell hyperplasia within the wall of a simple cyst and in the ovarian hilus is described. OBSERVATION: An 80 year-old woman complained of a 10-year history of severe androgenic alopecia associated with very mild facial hirsutism, without others signs of virilization. Hormonal blood levels showed markedly elevated testosterone. Computed tomographic scan of the adrenals and the ovaries revealed an enormous left ovarian cystic mass. Bilateral hystero-ophorectomy was performed. Histological examination demonstrated bilateral Leydig cell hyperplasia within the wall of the cyst and in the right ovarian hilus. Two months postoperative hormonal evaluation demonstrated dramatically decreased plasma levels of testosterone. COMMENTARY: The clinical, X ray and histologic aspects of this case, although rare, show that the presence of virilization should lead to a search for an androgen-secreting ovarian or adrenal tumor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11908171

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  2 in total

1.  Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.

Authors:  Mohamed K M Shakir; Andrea N Snitchler; Nicole O Vietor; Vinh Q Mai; Thanh D Hoang
Journal:  AACE Clin Case Rep       Date:  2020-12-28

2.  MULTILOCULAR PURE LEYDIG CELL TUMOR OF OVARY, FALLOPIAN TUBE, AND EXTRAOVARIAN SOFT TISSUE.

Authors:  Marie Boehnisch; Uwe Lindner; Touhama Salameh; Anja Gebbert; Lutz Kaltofen; Mike Krah; Olaf Dirsch
Journal:  AACE Clin Case Rep       Date:  2019-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.